ACN
47
-5
RRC
52
-6
VMC
53
-4
INTU
58
-3
K
51
-3
CFG
74
2
EXPD
43
-4
STZ
52
-6
SWK
50
-5
AA
56
15
HST
39
-3
XEL
67
2
PDCO
29
2
MS
77
-2
IFF
47
-4
AMT
37
3
ISRG
71
-5
TSN
50
-2
RSG
65
-3
NEM
40
3
ACN
47
-5
RRC
52
-6
VMC
53
-4
INTU
58
-3
K
51
-3
CFG
74
2
EXPD
43
-4
STZ
52
-6
SWK
50
-5
AA
56
15
HST
39
-3
XEL
67
2
PDCO
29
2
MS
77
-2
IFF
47
-4
AMT
37
3
ISRG
71
-5
TSN
50
-2
RSG
65
-3
NEM
40
3
Financhill
Back

Globant SA Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
12

GLOB
Globant SA

Last Price:
204.05
Seasonality Move:
4.45%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Sell
12
Globant SA (GLOB) is a Sell

Is Globant SA a Buy, Sell or Hold?

  • The current Globant SA [GLOB] share price is $203.29. The Score for GLOB is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • GLOB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GLOB Stock Price Chart

What is Globant SA's stock price today?

  • The Globant SA share price today is $203.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLOB is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

GLOB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.49 Buy
Relative Strength Index (14 RSI): 38.99 Sell
Chaikin Money Flow: -851553 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (210.31 - 228.65) Sell
Bollinger Bands (100): (185.89 - 214.19) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

GLOB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 227.78 Sell
20-day SMA: 220.84 Sell
50-day SMA: 208.54 Sell
200-day SMA: 197.07 Buy
8-day EMA: 223.29 Sell
20-day EMA: 220.29 Sell
50-day EMA: 211.59 Sell
200-day EMA: 199.3 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Globant SA Earnings Growth & GLOB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.99 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Globant SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):